These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1678592)

  • 1. [Circulating serum STN antigen as a prognostic marker in epithelial ovarian cancer].
    Kobayashi H; Terao T; Kawashima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1651-5. PubMed ID: 1678592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum sialyl Tn antigen as a prognostic marker in patients with epithelial ovarian cancer].
    Kobayashi H; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):14-20. PubMed ID: 1541859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies MA54 and MA61 as potential reagents in the prognosis of patients with ovarian cancer.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Terao T
    Gynecol Oncol; 1993 Apr; 49(1):80-5. PubMed ID: 8482565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of preoperative serum sialyl Tn antigen levels in prognosis of patients with gastric cancer.
    Takahashi I; Maehara Y; Kusumoto T; Yoshida M; Kakeji Y; Kusumoto H; Furusawa M; Sugimachi K
    Cancer; 1993 Sep; 72(6):1836-40. PubMed ID: 8364861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.
    Hashiguchi Y; Kasai M; Fukuda T; Ichimura T; Yasui T; Sumi T
    Pathol Oncol Res; 2016 Jul; 22(3):501-4. PubMed ID: 26678075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.
    Lundin M; Nordling S; Roberts PJ; Lundin J; Carpelan-Holmström M; von Boguslawsky K; Haglund C
    Oncology; 1999 Jul; 57(1):70-6. PubMed ID: 10394128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of serum sialyl Tn antigen levels in patients with gynecologic tumors].
    Shimizu C; Inoue M; Ogawa H; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1537-42. PubMed ID: 2273309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer.
    Terashima S; Takano Y; Ohori T; Kanno T; Kimura T; Motoki R; Kawaguchi T
    Surg Today; 1998; 28(7):682-6. PubMed ID: 9697259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
    Al-Alem L; Prendergast JM; Clark J; Zarrella B; Zarrella DT; Hill SJ; Growdon WB; Pooladanda V; Spriggs DR; Cramer D; Elias KM; Nazer RI; Skates SJ; Behrens J; Dransfield DT; Rueda BR
    J Ovarian Res; 2024 Apr; 17(1):71. PubMed ID: 38566237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].
    Tanaka T; Iwasaka T; Hayashi Y; Hachisuga T; Yokoyama M; Ohkuma Y; Matsuo N; Fukuda K; Sugimori H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1157-61. PubMed ID: 1975831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.
    Victorzon M; Nordling S; Nilsson O; Roberts PJ; Haglund C
    Int J Cancer; 1996 Jan; 65(3):295-300. PubMed ID: 8575847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    Br J Cancer; 1992 Nov; 66(5):984-5. PubMed ID: 1419648
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
    Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical usefulness of serum sialyl Le(x)-i measurement in patients with ovarian cancer].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):15-9. PubMed ID: 2564410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sialyl-tn antigen level as a prognostic indicator in patients with gastric-cancer.
    Maeda K; Chung Y; Onoda N; Nakanishi I; Nitta A; Arimoto Y; Yamada N; Kondo Y; Kato Y; Sowa M
    Int J Oncol; 1994 Jan; 4(1):129-32. PubMed ID: 21566901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.